We are live on ! Find out more
MFG

Merit Financial Group Portfolio holdings

AUM $16.4B
1-Year Est. Return 25.17%
This Fund
S&P 500
This Quarter Est. Return
+15.31%
1 Year Est. Return
+25.17%
3 Year Est. Return
+67.35%
5 Year Est. Return
+62.06%
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$2.92B
Cap. Flow
+$1.08B
Cap. Flow %
6.61%
Top 10 Hldgs %
20%
Holding
2,466
New
352
Increased
1,192
Reduced
768
Closed
106

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 4.25%
3 Industrials 3.95%
4 Consumer Discretionary 2.93%
5 Healthcare 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRC
2301
Commerce.com Inc Series 1
CMRC
$251M
$40.8K ﹤0.01%
+13,781
New +$39.5K
DNUT icon
2302
Krispy Kreme
DNUT
$569M
$40.7K ﹤0.01%
+11,530
New +$41.2K
ECC
2303
Eagle Point Credit Company
ECC
$489M
$40.6K ﹤0.01%
10,921
-138
-1% -$550
JELD icon
2304
JELD-WEN Holding
JELD
$101M
$40.4K ﹤0.01%
26,964
+13,676
+103% +$21.1K
SITC icon
2305
SITE Centers
SITC
$235M
$40K ﹤0.01%
+10,087
New +$52.6K
CNDT icon
2306
Conduent
CNDT
$251M
$39.7K ﹤0.01%
27,179
+5,052
+23% +$7.84K
ORGO icon
2307
Organogenesis Holdings
ORGO
$337M
$39.4K ﹤0.01%
+16,211
New +$39.6K
MDT icon
2308
CALL
Medtronic
MDT
$106B
$39.1K ﹤0.01%
+500
New +$40.3K
RC
2309
Ready Capital
RC
$256M
$39.1K ﹤0.01%
+22,336
New +$39.2K
CYH icon
2310
Community Health Systems
CYH
$465M
$38.7K ﹤0.01%
+11,599
New +$34.1K
REAX icon
2311
Real Brokerage
REAX
$453M
$38.7K ﹤0.01%
21,254
+367
+2% +$745
PSQH icon
2312
PSQ Holdings
PSQH
$10.1M
$37.8K ﹤0.01%
6,254
-13
-0.2% -$115
EDIT icon
2313
Editas Medicine
EDIT
$457M
$37.5K ﹤0.01%
11,566
-10
-0.1% -$29
AMC icon
2314
AMC Entertainment Holdings
AMC
$1.73B
$36.4K ﹤0.01%
+19,163
New +$33K
ALDX icon
2315
Aldeyra Therapeutics
ALDX
$102M
$35.5K ﹤0.01%
16,664
-3,015
-15% -$5.18K
WTI icon
2316
W&T Offshore
WTI
$519M
$32.6K ﹤0.01%
+10,364
New +$38.4K
CLVT icon
2317
Clarivate
CLVT
$1.53B
$32.3K ﹤0.01%
+14,936
New +$36.5K
LRMR icon
2318
Larimar Therapeutics
LRMR
$384M
$31.3K ﹤0.01%
+10,254
New +$40.7K
BNC
2319
CEA Industries
BNC
$121M
$30.2K ﹤0.01%
11,086
IWM icon
2320
CALL
iShares Russell 2000 ETF
IWM
$82.2B
$30K ﹤0.01%
+100
New +$28.1K
PFE icon
2321
CALL
Pfizer
PFE
$143B
$28.9K ﹤0.01%
+1,200
New +$31.4K
BAC icon
2322
CALL
Bank of America
BAC
$430B
$28.5K ﹤0.01%
+500
New +$26.6K
GOSS icon
2323
Gossamer Bio
GOSS
$83.2M
$27.9K ﹤0.01%
169,596
+15,155
+10% +$4.23K
DHF
2324
BNY Mellon High Yield Strategies Fund
DHF
$176M
$26.9K ﹤0.01%
11,097
+63
+0.6% +$152
EGHT icon
2325
8x8 Inc
EGHT
$267M
$26.4K ﹤0.01%
15,465
-12,799
-45% -$25.8K

Similar funds

Merit Financial Group's Q2 2026 Portfolio in Review

As of Q2 2026, Merit Financial Group held 2,466 positions worth $16.4B, up 22% from $13.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Merit Financial Group deployed $1.08B of net new capital in Q2 2026, opening 352 new positions and adding to 1,192 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 1,644,090 shares worth $46.1M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $68.9M trimmed.

  • Merit Financial Group's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 1,644,090 shares worth $46.1M.
  • Merit Financial Group added most to Vanguard Mega Cap Growth ETF in Q2 2026, an estimated $79.4M increase.
  • Merit Financial Group's biggest Q2 2026 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $68.9M.
  • Merit Financial Group fully exited Amplify TLT U.S. Treasury 12% Option Income ETF in Q2 2026, selling an estimated $8.21M.
  • Merit Financial Group's ten largest holdings make up 20% of its $16.4B portfolio in Q2 2026.
  • Merit Financial Group opened 352 new positions and closed 106 in Q2 2026.
  • Merit Financial Group's portfolio value rose 22% quarter-over-quarter to $16.4B.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.